The EPoC grant from Delaware Bioscience CAT funds bioscience research that advances lab innovations toward forming new Delaware-based startups.
Funder: Delaware Bioscience Center for Advanced Technology (CAT)
Due Dates (Anticipated): January 2027 (Letter of Intent) | March 2027 (Full application) | May 2027 (Full application)
Funding Amounts: Up to $100,000 for one year (single or multi-PI); typical range $75,000–$100,000.
Summary: Supports bioscience research aimed at forming new Delaware-based businesses, bridging early-stage innovation to startup launch.
Key Information: Letter of Intent required before full proposal; only one active CAT grant per PI at a time.
The Entrepreneurial Proof of Concept (EPoC) grant, part of the Delaware Bioscience Center for Advanced Technology (CAT) program, accelerates the translation of bioscience research into new Delaware-based companies. Administered by the Delaware Biotechnology Institute, EPoC provides targeted proof-of-concept funding to help academic or early-stage research teams move innovations from the lab toward commercial viability and startup formation. The program is designed to foster innovation, stimulate economic growth, and support the development of a thriving life sciences sector in Delaware.